Old Web
English
Sign In
Acemap
>
authorDetail
>
Garry Schwartz
Garry Schwartz
Carolinas Healthcare System
Medicine
Erlotinib
Gastroenterology
Bevacizumab
Carboplatin
4
Papers
100
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II Trial
2012
Journal of Clinical Oncology
Mark A. Socinski
Thomas E. Stinchcombe
Dominic T. Moore
Scott N. Gettinger
Roy H. Decker
W. Jeffrey Petty
A. William Blackstock
Garry Schwartz
Scott P. Lankford
Amir H. Khandani
David E. Morris
Show All
Source
Cite
Save
Citations (72)
Phase I/II trial of bevacizumab (B) and erlotinib (E) with induction (IND) and concurrent (CON) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic conformal radiotherapy (TCRT) in stage III non-small cell lung cancer (NSCLC).
2011
Journal of Clinical Oncology
T. Stinchcombe
M. A. Socinski
Dominic T. Moore
Scott N. Gettinger
Roy H. Decker
William J. Petty
A.W. Blackstock
Garry Schwartz
Scott P. Lankford
David E. Morris
Show All
Source
Cite
Save
Citations (8)
1